NCT06642987View on ClinicalTrials.gov

Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

November 3, 2023

Study Completion Date

February 23, 2024

Conditions

Gastric Ulcer

Interventions

DRUG

Vonoprazan Test 20mg

1 tablets orally once a day

DRUG

Vonoprazan Reference 20mg

1 tablets orally once a day

Trial Locations (1)

Unknown

Seok Gyeong Medical Foundation Central Hospital, Siheung-si

All Listed Sponsors

lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT06642987 - Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects. | Biotech Hunter | Biotech Hunter